RE:RE:I think I’m more a realist. They went from .07 to $1.05 in a short period of time based on them starting clinical trials and good test results. What do you think will happen when they get the reakl things...FDA approval, HC approval, orders for millions of units per month. Venowave itself might prove to be worth the current share price.